World’s First Malaria Vaccine To Be Tested In Three African Countries [Report] By Carie P. email@example.com | Apr 25, 2017 06:48 PM EDT Three countries will get the opportunity to receive the world's first malaria vaccine which will start in the year 2018. According to the latest reports, Ghana, Malawi, and Kenya will be the first nations which shall be given the malaria vaccines. This vaccine which is used to fight malaria is called RTS, S that has been made to develop the immune system to combat the malaria parasite. This malaria has been brought by mosquito bites. And as per World Health Organization, this vaccine will be able to save millions of lives of people. Despite this latest development, experts are still not sure if this malaria vaccine can also be applied in some of the economically-challenged countries as reported on BBC. What is more important at the moment is that this vaccine will be given to those three priority countries mostly in Africa. For the administration of this world's first malaria vaccine, it needs to be given four times, once a month during its first three months and after 18 months, it will already increase the to fourth dose. When these vaccines have been tested, the administration of these was done in a well-operated and fully-controlled clinic. Experts are not sure if they will also achieve the same result if this will be administered in a place where there is a limited health care. That is also the main reason why WHO needs to administer this first in the above-mentioned three countries to determine if they could already proceed after with its full malaria vaccine program. As reported on CNN, this will also help them check if the result is safe and effective for those people afflicted with the said disease. The administration of this malaria vaccine in those countries would really help mitigate the spread of the infection caused by malaria. That's why this is really great news and will even help them make better decisions for the use of the vaccine. If this world's first malaria vaccine will be combined with the current medical interventions, it will even help the vaccine achieve greater efficiency and as a result, will save thousands of lives in Africa. Further, for its pilot testing, it will involve 750,000 children aged between 1 to 5 years old.